Company / Free Cash Flow
Beta Bionics, Inc. Free Cash Flow History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$56.2M
FY2025
5-year range
-$56.2M / -$32.8M
FY2023-FY2025
Trend
-8.8%
vs FY2024
Sector context
#133 of 151
Health Care
What the data says
Beta Bionics, Inc.'s free cash flow of -$56M is lower than 88% of companies in the Health Care sector (FY2025). Declined from -$33M to -$56M over the past 2 years.
Based on SEC 10-K filings.
-$56M in FY2025.
Declined from -$33M to -$56M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 151This company -$56.2M Sector average $779.8M
▼
-107.2% below sector average
Key checks
Key Insights
- In FY2025, free cash flow decreased 8.8% year-over-year.
- Ranks #133 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$56.2M | -8.8% |
| FY2024 | -$51.7M | -57.3% |
| FY2023 | -$32.8M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026